Premature Ejaculation Treatment Guidelines

Introduction to PE Management

The American Urological Association guideline on PE pharmacologic management recommends paroxetine, sertraline, fluoxetine, and clomipramine as evidence-based options, but does not include escitalopram among recommended SSRIs 2, 3

Paroxetine 20 mg daily is the most effective SSRI, providing an 8.8-fold increase in IELT and is recommended as the preferred off-label SSRI by the AUA 1
Daily SSRI therapy provides more consistent and stronger ejaculatory delay than on-demand dosing, with paroxetine 10-20 mg daily being the most consistent option 4
Sertraline 25-200 mg daily is another effective option with established guideline support 2, 4

Never combine escitalopram with MAOIs due to risk of serotonin syndrome 1
Monitor patients under age 24 or those with comorbid depression for suicidal ideation 1
Do not use escitalopram in patients with bipolar depression due to risk of mania 1
Never abruptly discontinue escitalopram after daily dosing, as this can precipitate SSRI withdrawal syndrome 1

Dapoxetine 30-60 mg on-demand (1-3 hours before intercourse) is specifically approved for PE in many countries and provides 2.5-3.0-fold IELT increase, though not FDA-approved in the USA 1, 4
Topical lidocaine/prilocaine spray increases IELT up to 6.3-fold with minimal systemic effects 4
Combination therapy of daily low-dose SSRI plus on-demand dosing may be considered for partial responders 4
Tramadol on-demand may provide up to 2.5-fold IELT increase, though use cautiously due to addiction potential 4

If ED coexists with PE, treat the ED first or concomitantly, as some acquired PE may be secondary to ED 3, 4
Patient satisfaction and quality of life are the primary outcome targets, not just IELT improvement 1, 4